16.12 USD
↘ 0.75 (4.45%)LIVE (AS OF 11:56 AM EDT)
Summit Therapeutics Inc. Common Stock
SMMTNASDAQ • USD
Market: OPEN
Open?$16.87
High?$17.02
Low?$16.00
Prev. Close?$16.87
Volume?1.1M
Avg. Volume?4.3M
VWAP?$16.45
Rel. Volume?0.25x
Bid / Ask
Bid?$16.09 × 100
Ask?$16.98 × 300
Spread?$0.89
Midpoint?$16.54
Valuation & Ratios
Market Cap?13.1B
Shares Out?776.2M
Float?134.6M
Float %?17.3%
P/E Ratio?N/A
P/B Ratio?23.98
EPS?-$1.55
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Address
601 BRICKELL KEY DRIVE
MIAMI, FL 33131
Phone: 305-203-2034
MIAMI, FL 33131
Phone: 305-203-2034
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.40Strong
Quick Ratio?7.40Strong
Cash Ratio?1.28Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?23.98HIGH▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-10.6CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-220.9%WEAK▾
ROA?-186.2%WEAK▾
Cash Flow & Enterprise
FCF?$-384533000
Enterprise Value?$13.0B
Fundamentals ratios updated end of day